News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
84,296 Results
Type
Article (10542)
Company Profile (6)
Press Release (73748)
Section
Business (22413)
Career Advice (565)
Deals (4120)
Drug Delivery (38)
Drug Development (14454)
Employer Resources (44)
FDA (2793)
Job Trends (2594)
News (43170)
Policy (4160)
Tag
Academia (581)
Alliances (4301)
ALS (39)
Alzheimer's disease (636)
Approvals (2776)
Artificial intelligence (30)
Bankruptcy (45)
Best Places to Work (1955)
Breast cancer (40)
Cancer (280)
Cardiovascular disease (30)
Career advice (484)
CAR-T (35)
Cell therapy (96)
Clinical research (11544)
Collaboration (85)
COVID-19 (586)
Data (387)
Diabetes (74)
Diagnostics (676)
Drug pricing (43)
Earnings (12470)
Employer resources (38)
Events (11144)
Executive appointments (59)
FDA (2963)
Funding (79)
Gene therapy (69)
GLP-1 (239)
Government (818)
Healthcare (2546)
Infectious disease (604)
Interviews (119)
IPO (1989)
Job creations (732)
Job search strategy (404)
Layoffs (205)
Legal (729)
Lung cancer (39)
Lymphoma (41)
Manufacturing (41)
Medical device (1762)
Medtech (1763)
Mergers & acquisitions (2177)
Metabolic disorders (200)
Neurodegenerative disease (48)
Neuroscience (818)
NextGen: Class of 2025 (856)
Non-profit (780)
Northern California (326)
Obesity (113)
Opinion (100)
Parkinson's disease (55)
Patents (30)
People (4320)
Phase I (3040)
Phase II (5124)
Phase III (4496)
Pipeline (204)
Podcasts (58)
Policy (48)
Postmarket research (518)
Preclinical (1061)
Rare diseases (76)
Real estate (472)
Regulatory (2991)
Research institute (434)
Resumes & cover letters (63)
Southern California (244)
Startups (397)
The Weekly (55)
United States (2869)
Vaccines (140)
Weight loss (104)
Date
Last 7 days (92)
Last 30 days (410)
Last 365 days (5577)
2025 (724)
2024 (5601)
2023 (5864)
2022 (7522)
2021 (7920)
2020 (7578)
2019 (6116)
2018 (4586)
2017 (4282)
2016 (4279)
2015 (4947)
2014 (3519)
2013 (2574)
2012 (2836)
2011 (2893)
2010 (2351)
Location
Africa (180)
Asia (4822)
Australia (1045)
California (674)
Canada (159)
China (47)
Colorado (30)
Europe (12430)
Florida (83)
Illinois (63)
Indiana (54)
Japan (36)
Maine (32)
Maryland (91)
Massachusetts (516)
Michigan (52)
Minnesota (60)
New Jersey (275)
New York (341)
North Carolina (91)
Northern California (326)
Pennsylvania (157)
South America (222)
Southern California (244)
Texas (110)
Washington State (77)
84,296 Results for "imidomics sl".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SELLAS Announces Positive Data from Phase 2a Trial of SLS009 in Combination with Zanubrutinib in DLBCL
February 21, 2025
·
6 min read
Press Releases
Saol Therapeutics announces FDA acceptance of New Drug Application for SL1009 for treatment of Pyruvate Dehydrogenase Complex Deficiency
January 28, 2025
·
3 min read
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Press Releases
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
February 21, 2025
·
6 min read
Press Releases
IMIDomics, Inc. Appoints Life Sciences Industry Leader Matthias Evers, Ph.D., to Board of Directors
September 18, 2024
·
3 min read
Press Releases
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
December 17, 2024
·
15 min read
Business
IMIDomics Establishes a License and Collaboration Partnership with the University of Barcelona to Advance Treatments for IMIDs
IMIDomics Inc. today announced a strategic license and collaboration agreement with the University of Barcelona (UB).
October 11, 2023
·
3 min read
Press Releases
Saol Therapeutics Announces Submission of New Drug Application (NDA) to the U.S. FDA for SL1009
December 4, 2024
·
4 min read
Pharm Country
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation Granted to SLS009 for the Treatment of Pediatric Acute Lymphoblastic Leukemia
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to SLS009, a highly selective CDK9 inhibitor, for the treatment of pediatric acute lymphoblastic leukemia (ALL).
June 24, 2024
·
4 min read
Press Releases
Tonix’s TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers
December 9, 2024
·
4 min read
1 of 8,430
Next
